CN105288518A - Traditional Chinese medicine composition for treating gout and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating gout and preparation method thereof Download PDF

Info

Publication number
CN105288518A
CN105288518A CN201510926932.3A CN201510926932A CN105288518A CN 105288518 A CN105288518 A CN 105288518A CN 201510926932 A CN201510926932 A CN 201510926932A CN 105288518 A CN105288518 A CN 105288518A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
gout
insoluble matter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510926932.3A
Other languages
Chinese (zh)
Inventor
华坚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510926932.3A priority Critical patent/CN105288518A/en
Priority to PCT/CN2015/098982 priority patent/WO2017101151A1/en
Publication of CN105288518A publication Critical patent/CN105288518A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • A61K36/8984Dendrobium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9064Amomum, e.g. round cardamom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine composition for treating gout and a preparation method thereof, relating to the field of traditional Chinese medicines. The traditional Chinese medicine composition for treating gout comprises the following components in parts by weight: 20-40 parts of kadsura pepper stem, 2-7 parts of Japanese climbing fern spore, 8-15 parts of herb of christina loosestrife, 8-15 parts of amur corktree bark, 8-15 parts of officinal magnolia bark, 8-15 parts of black beans, 2-7 parts of Indian buead, 2-7 parts of Chinese magnoliavine fruit, 2-7 parts of liquorice root, 2-7 parts of Chinese pulsatilla root, 2-7 parts of officinal magnolia bark, 2-7 parts of zedoray rhizome, 2-7 parts of tortoise shell, 2-7 parts of oriental waterplantain rhizome, 8-15 parts of dried tangerine peel, 2-7 parts of chicken gizzard-membrane, 2-7 parts of unibract fritillary bulb, 2-7 parts of villous amomum fruit, 2-7 parts of stem of noble dendrobium, 2-7 parts of myrrh and 8-15 parts of suberect spatholobus stem. The composition is prepared by drying and grinding all the raw materials and then adding water to decoct the powder. The traditional Chinese medicine composition for treating gout is simple in preparation process and has obvious curative effects.

Description

A kind of Chinese medicine composition for the treatment of gout and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine composition.
Background technology
Gout is the crystal dependency arthrosis caused by monosodium urate salt (MSU) deposits, directly related with the hyperuricemia caused by purine metabolic disturbance and (or) underexcretion, refer in particular to acute characteristic arthritis and chronic gout stone disease.Along with the development of society, the quickening of rhythm of life, the increase of life stress, the change of dietary structure, patient with gout number is also in increase.Gout is more common in middle-aged male, and women only accounts for 5%, mainly postmenopausal women, and current gout has rejuvenation trend.The natural history of gout can be divided into the fourth phase, i.e. asymptomatic hyperuricemia phase, acute stage, intermission, chronic phase.The outbreak of gout brings considerable distress to patient.The Western medicine of general treatment gout has side effect more or less, and easily recurs, and gout is effected a radical cure.
Summary of the invention
For above-mentioned technical problem, the invention provides a kind of Chinese medicine composition for the treatment of gout and preparation method thereof.The Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Caulis Piperis Kadsurae 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
Further, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Caulis Piperis Kadsurae 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
Particularly, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Caulis Piperis Kadsurae 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
The preparation method of the Chinese medicine composition for the treatment of gout of the present invention is: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 ~ 7 times of weight, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
Particularly, by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
In key component of the present invention:
Caulis Piperis Kadsurae acrid in the mouth, hardship, slightly warm in nature.Return Liver Channel.Wind-damp dispelling, the meridian dredging, stopping numbness pain.For anemofrigid-damp arthralgia, arthrodynia of extremities, the contracture of muscle arteries and veins, joint stuffiness.
Herba Lysimachiae sweet in the mouth, salty, cold nature.Return liver, gallbladder, kidney, urinary bladder channel.Dampness removing jaundice eliminating, inducing diuresis for treating stranguria syndrome, removing toxic substances and promoting subsidence of swelling.For jaundice due to damp-heat, gallbladder-distention hypochondriac pain, stranguria caused by urinary stone, pyretic stranguria, difficulty and pain in micturition, carbuncle furuncle, snake bite and insect sting.
Cortex Phellodendri bitter in the mouth, cold in nature.Return kidney, urinary bladder channel.Have heat clearing and damp drying, pathogenic fire purging removes steams, effect of detoxification sore treatment.For damp-heat dysentery, jaundice dark coloured urine, leukorrhagia pudendal pruritus, the puckery pain of pyretic stranguria, beriberi flaccidity is knitted, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema eczema.Stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire.For hyperactivity of fire caused by deficiency of YIN, night sweat hectic fever due to YIN-deficiency.
Cortex Magnoliae Officinalis bitter in the mouth, pungent, warm in nature, return spleen, stomach, lung, large intestine channel.Dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards is except full.For humidity hysteresis damaging the spleen and stomach, gastral cavity painful abdominal mass is vomited and diarrhoea, and stagnation of QI due to dyspepsia, abdominal distention constipation, phlegm retention is breathed with cough.
Caulis Spatholobi sweet in the mouth, hardship, warm in nature, return liver, kidney channel, blood circulation promoting and enriching, menstruction regulating and pain relieving, relaxing muscles and tendons and activating QI and blood in the collateral.For menoxenia, dysmenorrhea, amenorrhea, rheumatic arthralgia, paralysis and numbness, blood deficiency and yellow complexion.
Semen sojae atricolor sweet in the mouth, cold nature, property is put down, enter spleen, kidney channel.The kidney invigorating tonifying YIN, invigorating spleen to remove dampness, except thermal detoxification.
Pericarpium Citri Reticulatae: bitter in the mouth, pungent, warm in nature.Return lung, spleen channel.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For distension and fullness in the abdomen, lack of appetite and vomiting, cough with copious phlegm.
The Chinese medicine composition for the treatment of gout of the present invention take Caulis Piperis Kadsurae as monarch drug, Herba Lysimachiae, Cortex Phellodendri, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Caulis Spatholobi, Semen sojae atricolor are ministerial drug, Spora Lygodii, Poria, Fructus Schisandrae Chinensis, the Radix Pulsatillae, Cortex Magnoliae Officinalis, Rhizoma Curcumae, Carapax et Plastrum Testudinis, Rhizoma Alismatis, Endothelium Corneum Gigeriae Galli, Bulbus Fritillariae Cirrhosae, Fructus Amomi, Herba Dendrobii, Myrrha are adjuvant drug, and Radix Glycyrrhizae is for making medicine.By scientific compatibility, each flavour of a drug synergism, full side has rheumatic arthralgia, carbuncle sore tumefacting virus, heat-clearing and toxic substances removing, blood stasis dispelling damp eliminating, promoting blood circulation to remove obstruction in the collateral, the merit of reducing swelling and alleviating pain, can be used for treating the outbreak of various types of gout, and side effect is little.Preparation technology is simple, evident in efficacy.
In order to understand better and implement, the following detailed description of the present invention.
Detailed description of the invention
preparation embodiment 1
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Caulis Piperis Kadsurae 20 parts, Spora Lygodii 2 parts, Herba Lysimachiae 8 parts, Cortex Phellodendri 8 parts, Cortex Magnoliae Officinalis 8 parts, 8 parts, Semen sojae atricolor, 2 parts, Poria, Fructus Schisandrae Chinensis 2 parts, 2 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 parts, Cortex Magnoliae Officinalis 2 parts, Rhizoma Curcumae 2 parts, Carapax et Plastrum Testudinis 2 parts, Rhizoma Alismatis 2 parts, Pericarpium Citri Reticulatae 8 parts, Endothelium Corneum Gigeriae Galli 2 parts, Bulbus Fritillariae Cirrhosae 2 parts, Fructus Amomi 2 parts, Herba Dendrobii 2 parts, Myrrha 2 parts, Caulis Spatholobi 8 parts clean, dry pulverize after add in the water of 4 times of weight, decoct 40min, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 times of weight, decoct 2h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 2
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Caulis Piperis Kadsurae 40 parts, Spora Lygodii 7 parts, Herba Lysimachiae 15 parts, Cortex Phellodendri 15 parts, Cortex Magnoliae Officinalis 15 parts, 15 parts, Semen sojae atricolor, 7 parts, Poria, Fructus Schisandrae Chinensis 7 parts, 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 7 parts, Cortex Magnoliae Officinalis 7 parts, Rhizoma Curcumae 7 parts, Carapax et Plastrum Testudinis 7 parts, Rhizoma Alismatis 7 parts, Pericarpium Citri Reticulatae 15 parts, Endothelium Corneum Gigeriae Galli 7 parts, Bulbus Fritillariae Cirrhosae 7 parts, Fructus Amomi 7 parts, Herba Dendrobii 7 parts, Myrrha 7 parts, Caulis Spatholobi 15 parts is cleaned, dry and add in the water of 7 times of weight after pulverizing, decoct 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 7 times of weight, decoct 5h, discard insoluble matter, merge extractive liquid, obtain.
preparation embodiment 3
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Caulis Piperis Kadsurae 25 parts, Spora Lygodii 4 parts, Herba Lysimachiae 9 parts, Cortex Phellodendri 9 parts, Cortex Magnoliae Officinalis 9 parts, 9 parts, Semen sojae atricolor, 4 parts, Poria, Fructus Schisandrae Chinensis 4 parts, 4 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 parts, Cortex Magnoliae Officinalis 4 parts, Rhizoma Curcumae 4 parts, Carapax et Plastrum Testudinis 4 parts, Rhizoma Alismatis 4 parts, Pericarpium Citri Reticulatae 9 parts, Endothelium Corneum Gigeriae Galli 4 parts, Bulbus Fritillariae Cirrhosae 4 parts, Fructus Amomi 4 parts, Herba Dendrobii 4 parts, Myrrha 4 parts, Caulis Spatholobi 9 parts clean, dry pulverize after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 6 times of weight, decoct 4h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 4
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Caulis Piperis Kadsurae 35 parts, Spora Lygodii 6 parts, Herba Lysimachiae 12 parts, Cortex Phellodendri 12 parts, Cortex Magnoliae Officinalis 12 parts, 12 parts, Semen sojae atricolor, 6 parts, Poria, Fructus Schisandrae Chinensis 6 parts, 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 6 parts, Cortex Magnoliae Officinalis 6 parts, Rhizoma Curcumae 6 parts, Carapax et Plastrum Testudinis 6 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 12 parts, Endothelium Corneum Gigeriae Galli 6 parts, Bulbus Fritillariae Cirrhosae 6 parts, Fructus Amomi 6 parts, Herba Dendrobii 6 parts, Myrrha 6 parts, Caulis Spatholobi 12 parts is cleaned, dry and add in the water of 5 times of weight after pulverizing, decoct 1.5h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct 2.5h, discard insoluble matter, merge extractive liquid, obtain.
preparation embodiment 5
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Caulis Piperis Kadsurae 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts is cleaned, dry and add in the water of 6 times of weight after pulverizing, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct 3h, discard insoluble matter, merge extractive liquid, obtain.
case embodiment
1. defend certain, man, 41 years old, gout history 5 years, clinical manifestation is Metatarsophalangeal joint red and swollen heat pain, joint joint stuffiness, intraarticular nodosity, start the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 1 in January, 2015, every day 2 times, each 200ml, transference cure after March, continue to take drug withdrawal after 3 months, so far without recurrence, whole drug administration process is without any side effects.
2. Zhang, man, 33 years old, gout history 3 years, clinical manifestation is finger thumb joint redness, falls ill and within the 3rd day, starts to take the Chinese medicine composition of the obtained treatment gout of the embodiment of the present invention 2, every day 3 times, each 200ml, transference cure after 3 days, whole drug administration process is without any side effects.
3. Wang, man, 57 years old, gout history 8 years, clinical manifestation was big toe congestion and swelling pain outside right crus of diaphragm, joint deformity, the symptoms such as heating.Start the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 3 in January, 2015, every day 3 times, each 300ml, transference cure after April, continues to take drug withdrawal after 3 months, and so far without recurrence, whole drug administration process is without any side effects.
The present invention is not limited to above-mentioned embodiment, if do not depart from the spirit and scope of the present invention to various change of the present invention or distortion, if these are changed and distortion belongs within claim of the present invention and equivalent technologies scope, then the present invention is also intended to comprise these changes and distortion.

Claims (5)

1. treat a Chinese medicine composition for gout, it is characterized in that being made up of the component of following weight portion: Caulis Piperis Kadsurae 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
2. the Chinese medicine composition for the treatment of gout according to claim 1, it is characterized in that being made up of the component of following weight portion: Caulis Piperis Kadsurae 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
3. the Chinese medicine composition for the treatment of gout according to claim 2, is characterized in that being made up of the component of following weight portion: Caulis Piperis Kadsurae 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
4. prepare the method for the Chinese medicine composition of the treatment gout described in claims 1 to 3 any one, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, add in the water of 4 ~ 7 times of weight again by insoluble matter, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
5. the preparation method of the Chinese medicine composition for the treatment of gout according to claim 4, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
CN201510926932.3A 2015-12-14 2015-12-14 Traditional Chinese medicine composition for treating gout and preparation method thereof Pending CN105288518A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201510926932.3A CN105288518A (en) 2015-12-14 2015-12-14 Traditional Chinese medicine composition for treating gout and preparation method thereof
PCT/CN2015/098982 WO2017101151A1 (en) 2015-12-14 2015-12-25 Gout treating traditional chinese medicine composition and preparation method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510926932.3A CN105288518A (en) 2015-12-14 2015-12-14 Traditional Chinese medicine composition for treating gout and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105288518A true CN105288518A (en) 2016-02-03

Family

ID=55186795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510926932.3A Pending CN105288518A (en) 2015-12-14 2015-12-14 Traditional Chinese medicine composition for treating gout and preparation method thereof

Country Status (2)

Country Link
CN (1) CN105288518A (en)
WO (1) WO2017101151A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017101151A1 (en) * 2015-12-14 2017-06-22 华坚 Gout treating traditional chinese medicine composition and preparation method therefor

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109420117A (en) * 2017-08-23 2019-03-05 临泽县锐翔科技开发有限责任公司 One group for treating the Chinese medicine of gout
CN111068043B (en) * 2019-12-23 2022-07-12 武汉轻工大学 Composition rich in chicory and inulin, preparation method thereof and preparation for preventing gout
CN112826888B (en) * 2021-02-26 2022-05-10 中国中医科学院中医临床基础医学研究所 Traditional Chinese medicine composition for gout and preparation method and application thereof
CN113261666B (en) * 2021-05-07 2022-08-16 云南品斛堂生物科技有限公司 Method and equipment for improving fragrance of dried dendrobe slices
CN116059154A (en) * 2021-10-29 2023-05-05 李宏亮 Tibetan medicine eight-ingredient Heg bath composition
CN115040581A (en) * 2022-07-27 2022-09-13 山东创新腐植酸科技股份有限公司 Gout bath lotion and preparation method thereof
CN118021897B (en) * 2024-04-12 2024-06-11 山东新时代药业有限公司 Pharmaceutical composition and application thereof in medicines for treating coronary heart disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102240378A (en) * 2010-05-10 2011-11-16 张金荣 Pharmaceutical composition for treating gout and preparation method thereof
CN104740424A (en) * 2013-12-30 2015-07-01 魏修彦 A method of treating gout

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288518A (en) * 2015-12-14 2016-02-03 华坚 Traditional Chinese medicine composition for treating gout and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102240378A (en) * 2010-05-10 2011-11-16 张金荣 Pharmaceutical composition for treating gout and preparation method thereof
CN104740424A (en) * 2013-12-30 2015-07-01 魏修彦 A method of treating gout

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017101151A1 (en) * 2015-12-14 2017-06-22 华坚 Gout treating traditional chinese medicine composition and preparation method therefor

Also Published As

Publication number Publication date
WO2017101151A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
CN105288518A (en) Traditional Chinese medicine composition for treating gout and preparation method thereof
CN103520497B (en) Chinese medicinal composition for treating gout and preparation method thereof
CN103041243A (en) Traditional Chinese medicine capsule for clearing heat, expelling noxious substances and removing acnes
CN103705809A (en) Traditional Chinese medicine for curing gout
CN103877286A (en) Orally taken medicine for treating erysipelas and preparation method thereof
CN103349693A (en) Preparation and using method of pure Chinese herbal medicine composition for treating allergic rhinitis
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN104042925A (en) Traditional Chinese medicinal composition for treating gout and preparation method thereof
CN103800697A (en) Traditional Chinese medicine composition for treating pharyngitis
CN105435100A (en) Traditional Chinese medicine composition for treating gout and preparation method thereof
CN102085300A (en) Traditional Chinese medicine composition for treating acne
CN104958520A (en) Traditional Chinese medicine for treating osteoarthritis
CN104547941A (en) Traditional Chinese medicine composition for preventing and treating cerebral thrombosis
CN104758668A (en) Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat
CN104547356A (en) Traditional Chinese medicine composition for treating heat evil attacking stomach type chronic gastritis
CN105288519A (en) Traditional Chinese medicine composition for treating gout and preparation method thereof
CN105311586A (en) Traditional Chinese medicine composition for treating gout and preparation method thereof
CN105343799A (en) Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition
CN105343802A (en) Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition
CN105343801A (en) Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition
CN105362951A (en) Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition
CN105853933A (en) Traditional Chinese medicine preparation for treating postoperative recurrence and metastasis of breast cancer and preparing method
CN104689072A (en) TCM (Traditional Chinese Medicine) composition for treating blood stasis binding and water retention type tympany
CN105125836A (en) Decoction medicament for treating erythema nodosum and preparation method thereof
CN105031462A (en) Traditional Chinese medicinal decoction for treating senile diabetes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160203